Search research articles
Contact Us
Filters
Showing results (51-60 of 94) with videos related to
Page
of 10
Sort By:
The Journal of Headache and Pain
|
November 5, 2022
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis
Anna P Andreou, Matteo Fuccaro, Bethany Hill, et al.
Expert Review of Neurotherapeutics
|
January 30, 2025
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis
Michail Vikelis, Dimitrios Rikos, Andreas A Argyriou, et al.
The Journal of Headache and Pain
|
June 6, 2022
Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis
J O Lloyd, B Hill, M Murphy, et al.
Brain : a Journal of Neurology
|
June 2, 2016
Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine
Anna P Andreou, Philip R Holland, Simon Akerman, et al.
Pain
|
August 16, 2020
Differential actions of indomethacin: clinical relevance in headache
Oliver Summ, Anna P Andreou, Simon Akerman, et al.
European Journal of Gastroenterology & Hepatology
|
September 10, 2019
Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitis
P Kourkoulis, C Kapizioni, G Michalopoulos, et al.
Ebiomedicine
|
December 24, 2023
Resistant and refractory migraine: clinical presentation, pathophysiology, and management
Raffaele Ornello, Anna P Andreou, Eleonora De Matteis, et al.
Annals of Neurology
|
October 31, 2012
Acid-sensing ion channel 1: a novel therapeutic target for migraine with aura
Philip R Holland, Simon Akerman, Anna P Andreou, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 10, 2023
Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis
Giorgio Lambru, Valeria Caponnetto, Bethany Hill, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 7, 1999
Prevalence of risk factors for cardiovascular disease in Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992
D B Langille, M R Joffres, K M MacPherson, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 94) with videos related to
Sort By:
Page
of 10
The Journal of Headache and Pain
|
November 5, 2022
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis
Anna P Andreou, Matteo Fuccaro, Bethany Hill, et al.
Expert Review of Neurotherapeutics
|
January 30, 2025
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis
Michail Vikelis, Dimitrios Rikos, Andreas A Argyriou, et al.
The Journal of Headache and Pain
|
June 6, 2022
Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis
J O Lloyd, B Hill, M Murphy, et al.
Brain : a Journal of Neurology
|
June 2, 2016
Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine
Anna P Andreou, Philip R Holland, Simon Akerman, et al.
Pain
|
August 16, 2020
Differential actions of indomethacin: clinical relevance in headache
Oliver Summ, Anna P Andreou, Simon Akerman, et al.
European Journal of Gastroenterology & Hepatology
|
September 10, 2019
Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitis
P Kourkoulis, C Kapizioni, G Michalopoulos, et al.
Ebiomedicine
|
December 24, 2023
Resistant and refractory migraine: clinical presentation, pathophysiology, and management
Raffaele Ornello, Anna P Andreou, Eleonora De Matteis, et al.
Annals of Neurology
|
October 31, 2012
Acid-sensing ion channel 1: a novel therapeutic target for migraine with aura
Philip R Holland, Simon Akerman, Anna P Andreou, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 10, 2023
Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis
Giorgio Lambru, Valeria Caponnetto, Bethany Hill, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 7, 1999
Prevalence of risk factors for cardiovascular disease in Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992
D B Langille, M R Joffres, K M MacPherson, et al.
Page
of 10